TCBWMS
IRD

Texas Capital Bank Wealth Management Services’s Opus Genetics IRD Stock Holding History

Texas Capital Bank Wealth Management Services’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$403K Buy
88,500
+10,500
+13% +$36.3K 0.02% 237
2025
Q4 		$157K Buy
+78,000
New +$158K 0.01% 326

Other funds holding IRD

CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Texas Capital Bank Wealth Management Services's IRD Position: Q1 2026 in Review

Texas Capital Bank Wealth Management Services increased its Opus Genetics (IRD) stake by 13% in Q1 2026, buying an estimated $36.3K and bringing the position to 88,500 shares worth $403K. The position accounts for 0.02% of the portfolio, ranked #237.

Texas Capital Bank Wealth Management Services first reported a position in IRD in Q4 2025 and has held it in 2 quarters since. 79 funds tracked by Wall St. Rank hold IRD as of Q1 2026.

  • Texas Capital Bank Wealth Management Services held 88,500 shares of Opus Genetics worth $403K as of Q1 2026.
  • Texas Capital Bank Wealth Management Services bought 10,500 Opus Genetics shares in Q1 2026, an estimated $36.3K.
  • Opus Genetics made up 0.02% of Texas Capital Bank Wealth Management Services's portfolio in Q1 2026, its #237 holding.
  • Texas Capital Bank Wealth Management Services first reported a position in Opus Genetics in Q4 2025 and has held it in 2 quarters since.
  • 79 funds tracked by Wall St. Rank held Opus Genetics as of Q1 2026.

Based on Texas Capital Bank Wealth Management Services's 13F filing for Q1 2026, filed 11 May 2026.